| Inna Shulyak, | |
|
226 Semanski St, Enumclaw, WA 98022-2009 | |
| (360) 802-7669 | |
| Not Available |
| Full Name | Inna Shulyak |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 226 Semanski St, Enumclaw, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114320470 | NPI | - | NPPES |
| LP60458064 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LP60458064 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Inna Shulyak, 226 Semanski St, Enumclaw, WA 98022-2009 Ph: () - | Inna Shulyak, 226 Semanski St, Enumclaw, WA 98022-2009 Ph: (360) 802-7669 |
News Archive
The New Jersey Hospital Association has expanded its Career Center by giving its members access to the National Healthcare Career Network (NHCN), an integrated alliance of nearly 300 recruiting career centers of professional associations.
The diagnosis of male fertility is usually performed through the observation of the sperm in the microscope. However, a normal quality semen does not guarantee an adequate fertility. In fact, there is a considerable proportion of cases of unexplained infertility and data suggest that abnormal sperm function may have a genetic or molecular origin.
PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.
The news about youth and diabetes keeps getting worse. The latest data from the national TODAY diabetes study shows that children who develop Type 2 diabetes are at high risk to develop heart, kidney and eye problems faster and at a higher rate than people who acquire Type 2 diabetes as adults.
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
› Verified 4 days ago
Heather Storm, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 42018 264th Ave Se, Enumclaw, WA 98022 Phone: 360-802-7492 Fax: 360-802-7500 | |
Jamie Lynn Prak, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 40903 236th Ave Se, Enumclaw, WA 98022 Phone: 360-825-6525 | |
Jordan Michelle Panian, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 40903 236th Ave Se, Enumclaw, WA 98022 Phone: 360-825-6525 | |
Mrs. Patricia Ann Norwood, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 226 Semanski St, Enumclaw, WA 98022 Phone: 360-802-7669 | |
Tami Louise Atkinson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 40903 236th Ave Se, Enumclaw, WA 98022 Phone: 360-825-6525 | |
Laura Ferrel, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 40903 236th Ave Se, Enumclaw, WA 98022 Phone: 360-825-6525 |